Clinical Trials on EBV Lymphomas in United Kingdom
Total 5027 results
-
Atara BiotherapeuticsNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompletedEBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk of Developing a Recurrent EBV LymphomaUnited States
-
Baylor College of MedicineThe Methodist Hospital Research InstituteRecruitingEBV-Related Hodgkin Lymphoma | EBV Related Non-Hodgkin's Lymphoma | EBV-Related Lymphoproliferative DisorderUnited States
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedLymphoproliferative Disorders | Hodgkin Lymphoma | EBV Related Non-Hodgkin's Lymphoma | NonHodgkin Lymphoma | EBV-Related PTLD | EBV Related Lymphoma | EBV Related Hodgkin's LymphomaUnited States
-
Atara BiotherapeuticsMemorial Sloan Kettering Cancer CenterCompletedEBV-induced Lymphomas | EBV-associated Malignancies | Transplant Patients With EBV Viremia at High Risk for Developing a Recurrent EBV LymphomaUnited States
-
Viracta Therapeutics, Inc.RecruitingEBV Related Non-Hodgkin's Lymphoma | Epstein-Barr Virus Associated Lymphoproliferative Disorder | EBV-Related PTLD | EBV Associated Lymphoma | EBV-Positive DLBCL, NOS | EBV Related PTCL, NOSUnited States, Spain, Italy, United Kingdom, Singapore, Taiwan, Korea, Republic of, Germany, Canada, Brazil, Australia, France, Malaysia, Hong Kong, Israel
-
Cell Medica LtdTerminatedLymphoma, Extranodal NK-T-Cell | EBVKorea, Republic of, United States, France, United Kingdom
-
HemaQuest Pharmaceuticals Inc.Boston UniversityTerminatedEBV Lymphomas | Lympho-proliferative DiseasesUnited States
-
Atara BiotherapeuticsRecruitingLymphoproliferative Disorders | Leiomyosarcoma | Stem Cell Transplant Complications | Solid Organ Transplant Complications | Epstein-Barr Virus (EBV)-Associated Diseases | EBV+ Post-transplant Lymphoproliferative Disease (EBV+ PTLD) | Allogeneic Hematopoietic Cell Transplant | EBV+ Sarcomas | EBV+ Lymphoproliferative... and other conditionsUnited States, Austria, Belgium, France, Italy, Spain, United Kingdom
-
Catherine BollardActive, not recruitingHodgkin Disease | Non Hodgkin Lymphoma | Leiomyosarcoma | Lymphoepithelioma | Severe Chronic Active EBV Infection Syndrome (SCAEBV)United States
-
Stanford UniversityNational Institutes of Health (NIH); AmgenCompletedLymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous Lymphoma | Lymphomas: Non-Hodgkin Diffuse Large B-Cell | Lymphomas: Non-Hodgkin Follicular / Indolent B-Cell | Lymphomas: Non-Hodgkin Mantle Cell | Lymphomas: Non-Hodgkin Marginal... and other conditionsUnited States
-
Abramson Cancer Center of the University of PennsylvaniaCompletedFollicular Lymphomas | CD19+ Diffuse Large B-cell Lymphomas | Mantle Cell LymphomasUnited States
-
M.D. Anderson Cancer CenterActive, not recruitingLymphomas | B-cell LymphomasUnited States
-
Stanford UniversityTerminatedMycosis Fungoides | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Peripheral T-Cell | Lymphomas: Non-Hodgkin Cutaneous LymphomaUnited States
-
Patrick C. Johnson, MDAstraZenecaRecruitingRefractory B-Cell Non-Hodgkin Lymphoma | Diffuse Large B-cell Lymphoma (DLBCL) | Grade 3b Follicular Lymphoma | Refractory Aggressive B-cell Lymphomas | Aggressive B-cell NHL | De Novo or Transformed Indolent B-cell Lymphoma | DLBCL, Nos Genetic Subtypes | T Cell/Histiocyte-rich Large B-cell Lymphoma and other conditionsUnited States
-
Royal Marsden NHS Foundation TrustCancer Research UKUnknownAngioimmunoblastic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Anaplastic Large Cell Lymphoma, ALK-Negative | Peripheral T-cell Lymphoma NOS | Hepatosplenic Gamma/ Delta T-cell LymphomaUnited Kingdom
-
University Hospital Southampton NHS Foundation...Hoffmann-La RocheTerminatedDiffuse Large B Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Relapsed Diffuse Large B-Cell LymphomaUnited Kingdom
-
Epizyme, Inc.CompletedFollicular Lymphoma | Marginal Zone Lymphoma | Advanced Solid Tumors | Mantle-Cell Lymphoma | Diffuse Large B Cell Lymphoma | Primary Mediastinal LymphomaUnited Kingdom
-
University of BirminghamPfizer; BloodwiseCompletedT-Cell Lymphoma Relapsed | T-Cell Lymphoma RefractoryUnited Kingdom
-
Royal Marsden NHS Foundation TrustUnknownMantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Marginal Zone Lymphoma (MZL)United Kingdom
-
Hoffmann-La RocheCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
University College, LondonCompletedDiffuse Large B-Cell LymphomaUnited Kingdom
-
Royal Marsden NHS Foundation TrustCelgene CorporationActive, not recruitingDiffuse Large B-Cell LymphomaUnited Kingdom
-
Royal Marsden NHS Foundation TrustHoffmann-La RocheTerminatedB-cell Lymphoma | Non-Hodgkin's LymphomaUnited Kingdom
-
GlaxoSmithKlineCompletedLymphoma, Large-Cell, DiffuseUnited Kingdom
-
Belfast Health and Social Care TrustQueen's University, Belfast; Northern Ireland Clinical Trials UnitTerminated
-
Ronald LevyPfizerCompletedLymphoma | Lymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Follicular / Indolent B-CellUnited States
-
GlaxoSmithKlineCompletedLymphoma, FollicularUnited Kingdom
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Mundipharma-EDO GmbHWithdrawnRelapsed or Refractory Diffuse Large B-cell LymphomaUnited Kingdom
-
Catherine BollardActive, not recruiting
-
4SC AGCompletedMycosis Fungoides | Sezary Syndrome | Cutaneous T Cell LymphomaUnited Kingdom
-
University College, LondonNovartis PharmaceuticalsActive, not recruiting
-
University College London HospitalsCompletedCardiovascular Diseases | Diffuse Large B Cell Lymphoma | Cardiotoxicity | B-cell Acute Lymphoblastic Leukemia | Primary Mediastinal Large B-cell Lymphoma (PMBCL) | B-cell Lymphoma Refractory | Cardiovascular Complication | B-cell Lymphoma RecurrentUnited Kingdom
-
The Christie NHS Foundation TrustTerminatedCD19 Positive Non-Hodgkin LymphomaUnited Kingdom
-
Genentech, Inc.CompletedNon-Hodgkin's Lymphoma, Solid CancersUnited Kingdom
-
University of SouthamptonMerck Sharp & Dohme LLCRecruitingDiffuse Large B Cell LymphomaUnited Kingdom
-
Codiak BioSciencesTerminatedCutaneous T-cell Lymphoma (CTCL)United Kingdom
-
Autolus LimitedRecruitingRelapsed or Refractory B Cell Acute Lymphoblastic Leukemia | Relapsed or Refractory B Cell Non-Hodgkin LymphomaUnited Kingdom
-
NovalGen Ltd.RecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | Non-small Cell Lung Cancer (NSCLC) | Small Lymphocytic Lymphoma | Malignant Melanoma | Chronic Lymphocytic LeukaemiaUnited Kingdom
-
Viracta Therapeutics, Inc.RecruitingNasopharyngeal Carcinoma | EBV-Related Gastric Carcinoma | EBV-Related Leiomyosarcoma | EBV Related Carcinoma | EBV-Related SarcomaUnited States, Hong Kong, Taiwan, Korea, Republic of, Singapore, Australia, Canada, Malaysia
-
Royal Marsden NHS Foundation TrustCompleted
-
Royal Marsden NHS Foundation TrustRecruitingBreast Implant-Associated Anaplastic Large Cell Lymphoma | Breast Implant; Complications | Capsular Contracture, ImplantUnited Kingdom
-
University College, LondonRecruiting
-
King's College Hospital NHS TrustCompletedHTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL)United Kingdom
-
GlaxoSmithKlineTerminated
-
National Institute of Allergy and Infectious Diseases...RecruitingCMV | HPV | EBV | HSV | VZVUnited States
-
University College, LondonCompleted
-
Oxford University Hospitals NHS TrustUniversity of Manchester; The Christie NHS Foundation Trust; Early Phase Cancer...Completed
-
University Hospital Southampton NHS Foundation...Cancer Research UK; The Christie NHS Foundation Trust; Celldex Therapeutics; Oxford... and other collaboratorsActive, not recruitingB Cell LymphomaUnited Kingdom
-
Medical Research CouncilCompletedLymphoma | LeukemiaUnited Kingdom